* Avid Bioservices Inc CDMO.OQ reported quarterly adjusted
earnings of 4 cents per share for the quarter ended in
January. The mean expectation of four analysts for the quarter
was for earnings of 4 cents per share.
* Revenue rose 44.5% to $31.51 million from a year ago;
analysts
expected $26.59 million.
* Avid Bioservices Inc's reported EPS for the quarter was 4
cents.
* The mean earnings estimate of analysts had risen by
about 33.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Avid Bioservices Inc shares had fallen by 37.8% this
quarter.
* The company reported quarterly net income of $2.25
million.
* Wall Street's median 12-month price target for Avid
Bioservices
Inc is $32.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated March 8 at 10:02 p.m. All
figures in US dollars unless otherwise stated